Kingsley began investing in the emerging legalised cannabis market in 2015, and is the only investment firm outside of the US to do so on a formal basis
Kingsley is the only firm to take a global approach to the legalised cannabis market and has founded and incubated two operating companies in the sector: Oxford Cannabinoid Technologies and Equinox International.
Should you be interested in investing in this high-growth sector, please contact firstname.lastname@example.org for more information.
Oxford Cannabinoid Technologies
About: OCT was founded in 2017 with its lead research partner, Oxford University. OCT is studying the molecular properties of cannabinoids and is developing cannabinoid-derived medication across cancer, pain, immunology and neurological conditions.
About: Equinox is an international cultivation and retail business focused on the UK and international cannabis markets, trading under several brands. Its first UK store (Soho, London) for its flagship brand, Mr Nice, is now open. Other Mr Nice stores around the world will be announced shortly.